Submit Your Feeds

Business News • PR NewsWire • Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress

Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress
Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress

KYOTO, Japan, July 28, 2011 /PRNewswire/ -- Inspiration Biopharmaceuticals, Inc. (Inspiration) today announced data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia

View More : http://www.prnewswire.com/news-releases/inspiration-biopharmaceuticals-announces-data-from-obi-1-pivotal-stage-program-i...
Releted News by prnewswire
MONOPOLY: You're in the Money Comes to Virgin Casino
Inspiration Biopharmaceuticals Announces Data from OBI-1 Pivotal-Stage Program in Hemophilia at 23rd ISTH Congress
La publicité pénètre les réseaux sociaux
Encision Reports 9.3% Revenue Increase in First Quarter Results
CDI Corp. Reports 2011 Second Quarter Results
Home Sitemap Contact Us
© businessNewsNewsNews.com